Oral/Nasal Endotracheal Tube, Reinforced (Covidien)
DeviceUse Oral/Nasal Endotracheal Tube, Reinforced (Covidien) for endotracheal intubation
NCT Number: NCT03368911
The purpose of this study is an evaluation of the effect of the reinforced endotracheal tube on post-operative hoarseness and sore throat undergoing thyroidectomy
Looking for future studies?
Notify Me20 year–70 year
All sexes
Interventional
Not applicable
Chonnam National University Hwasun Hopspital, Hwasun, Jeollanamdo, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use Oral/Nasal Endotracheal Tube, Reinforced (Covidien) for endotracheal intubation
Use TaperGuard oral tracheal tube (Covidien) for endotracheal intubation
Time frame: assess after 1hours after operation
compare the incidence and degree of the hoarseness after thyroidectomy
Time frame: assess after 1hours after operation
compare the incidence and degree of the sore throat after thyroidectomy
Time frame: assess after 24 hours after operation
compare the incidence and degree of the hoarseness after thyroidectomy
Time frame: assess after 24hours after operation
compare the incidence and degree of the sore throat after thyroidectomy
Time frame: assess after 48 hours after operation
compare the incidence and degree of the hoarseness after thyroidectomy
Time frame: assess after 48 hours after operation
compare the incidence and degree of the sore throat after thyroidectomy
Chonnam National University Hospital
Other
The Effect of Reinforced Endotracheal Tube on Post-operative Hoarseness
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00925613
Apnea, Cough
Montreal, Quebec, Canada
View Trial DetailsNCT05357222
Hoarseness, Laryngeal Diseases
Salt Lake City, Utah, United States
View Trial DetailsNCT03846713
Hoarseness, Infections
Seoul, South Korea
View Trial DetailsNCT05048628
Hoarseness, Infections
Famagusta, North Cyprus Via Mersin 10, Turkey, Ammochostos, Cyprus
View Trial Details